Last reviewed · How we verify
NCT05153031
Impact of Percutaneous Cholecystostomy in the Management of Acute Cholecystitis.
trial testing lithiasic in Acute Cholecystitis in 195 participants. Completed in 1 November 2021.
28 February 2021
Quick facts
| Lead sponsor | Hospital General Universitario de Alicante |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 195 |
| Start date | 1 January 2016 |
| Primary completion | 28 February 2021 |
| Estimated completion | 1 November 2021 |
Drugs / interventions tested
- lithiasic
- Emergency surgery
- cholecystectomy
Conditions studied
- Acute Cholecystitis — all drugs for Acute Cholecystitis →
- Percutaneous Cholecystostomy — all drugs for Percutaneous Cholecystostomy →
Sponsor
Hospital General Universitario de Alicante
Who can join
17 and older, any sex, with Acute Cholecystitis or Percutaneous Cholecystostomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Percutaneous cholecystostomy (PC) is an increasingly performed procedure for acute cholecystitis (AC), safe and less invasive than laparoscopic cholecystectomy, very useful in selected patients (severe comorbidities, not suitable for surgery/general anesthesia,..) The investigators conduct a retrospective observational study. Period: 2016-2021. Inclusion criteria: Patients treated with PC for AC. Tokyo guidelines TG13/18 the investigators algorithm to treat AC. The characteristics of the sample undergoing Percutaneous Cholecystostomy, main indications, evolution and clinical results were reported in an initial observational study. Subsequently, a retrospective analytical study was designed to compare various cohorts: lithiasic vs alithiasic Acute Cholecystitis, elective vs emergency surgery or management with PC alone.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of percutaneous cholecystostomy in the management of acute cholecystitis: a retrospective cohort study at a tertiary center.
Rubio-García JJ, Velilla Vico D, Villodre Tudela C, Irurzun López J, et al · · 2023 · cited 9× · PMID 36991301 · DOI 10.1007/s13304-023-01499-3
Verify or expand the search:
- PubMed search for NCT05153031
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Cholecystitis
Currently open trials in the same condition.
- NCT07161960 — Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE) · NA · recruiting
- NCT06967597 — Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage: FUGITI · NA · recruiting
- NCT07006298 — One-year Outcomes by Index Treatment in Elderly Patients With Acute Cholecystitis · recruiting
- NCT06287112 — Prevention of Acute Cholecystitis With ETGBD · NA · recruiting
- NCT05732480 — Influence of Gut Microbiome in Gallstone Disease · recruiting
Other Hospital General Universitario de Alicante trials
Trials by the same sponsor.
- NCT06967597 — Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage: FUGITI · NA · recruiting
- NCT06899269 — SPAROBOPAN Project (Spanish Registry of Robotic Pancreatic Surgery) · not yet recruiting
- NCT06076824 — Glucocorticoid Treatment in Transaortic Valve Replacement to Reduce the Incidence of Conduction Disturbances (GLUCO-TAVR · Phase 4 · unknown
- NCT05689268 — EUS-PPG vs HVPG in Portal Hypertension · NA · completed
- NCT05888753 — Textbook Outcome in Adrenal Neoplasms · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05153031 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital General Universitario de Alicante
- Last refreshed: 10 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153031.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing